|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Nausea | |||||
| Vomiting | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Postoperative Nausea and Vomiting | |||||
| 3 | More general conditions related to this trial | ||||
| Pathologic Processes | |||||
| Postoperative Complications | |||||
| Signs and Symptoms | |||||
| Signs and Symptoms, Digestive | |||||
| 4 | Interventions listed in this trial | ||||
| Emend (Aprepitant) + Placebo | |||||
| Scopolamine + Emend (Aprepitant) | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Aprepitant | |||||
| Butylscopolammonium Bromide | |||||
| Scopolamine | |||||
| 6 | More general drug interventions related to this trial | ||||
| Adjuvants, Anesthesia | |||||
| Antiemetics | |||||
| Autonomic Agents | |||||
| Central Nervous System Agents | |||||
| Cholinergic Agents | |||||
| Cholinergic Antagonists | |||||
| Gastrointestinal Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Muscarinic Antagonists | |||||
| Mydriatics | |||||
| Neurotransmitter Agents | |||||
| Parasympatholytics | |||||
| Peripheral Nervous System Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| Drexel University | |||||
| Merck | |||||